ArticlePharmacology, biochemistry, and behavior2019

Assessing the contribution of opioid- and dopamine-related genetic polymorphisms to the abuse liability of oxycodone.

Jermaine D Jones et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.